MBB Public Markets I LLC Takes Position in Colgate-Palmolive Company $CL

MBB Public Markets I LLC purchased a new stake in shares of Colgate-Palmolive Company (NYSE:CL) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 3,372 shares of the company’s stock, valued at approximately $316,000.

A number of other institutional investors have also recently made changes to their positions in CL. Price T Rowe Associates Inc. MD grew its holdings in shares of Colgate-Palmolive by 18.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock valued at $3,186,651,000 after buying an additional 5,269,140 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Colgate-Palmolive during the first quarter valued at approximately $217,593,000. Goldman Sachs Group Inc. grew its holdings in shares of Colgate-Palmolive by 34.5% during the first quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock valued at $747,762,000 after buying an additional 2,045,191 shares during the last quarter. Diamond Hill Capital Management Inc. grew its holdings in shares of Colgate-Palmolive by 45.0% during the first quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company’s stock valued at $521,250,000 after buying an additional 1,727,105 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of Colgate-Palmolive by 10,601.7% during the first quarter. GAMMA Investing LLC now owns 1,105,379 shares of the company’s stock valued at $103,574,000 after buying an additional 1,095,050 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of several research reports. Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $88.00 to $83.00 and set an “underweight” rating on the stock in a report on Monday, August 4th. Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. JPMorgan Chase & Co. dropped their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Barclays raised their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 15th. Finally, UBS Group dropped their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a report on Thursday, July 17th. Seven investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $98.00.

Colgate-Palmolive Trading Up 0.2%

Shares of Colgate-Palmolive stock opened at $84.33 on Wednesday. The company’s fifty day simple moving average is $86.45 and its 200-day simple moving average is $89.69. The stock has a market capitalization of $68.16 billion, a PE ratio of 23.69, a P/E/G ratio of 4.38 and a beta of 0.35. Colgate-Palmolive Company has a 1-year low of $82.40 and a 1-year high of $107.76. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.91 EPS. As a group, equities analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Friday, July 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.43%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.